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Abstract
The present review summarizes results of experiments, mostly performed on rodents, regarding 
the effects of fish oil (FO) and its biologically active constituents, eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), on the healing of cutaneous wounds, but also of selected other types 
of injury. Structure, metabolism and functions of EPA/DHA in an organism are briefly mentioned, 
with an emphasis on the ability of these long-chain polyunsaturated fatty acids to modulate 
inflammation. Wound healing as a complex programmed sequence of cellular and molecular 
processes including inflammation, cell migration, angiogenesis, synthesis of provisional matrix, 
collagen deposition and reepithelialisation is briefly described. Markers for evaluation of the 
healing process include planimetry indices, tensile strength, quantification of collagen synthesis 
including hydroxyproline determination, histopathology/immunohistochemistry and genomic/
proteomic markers. As far as effects on wound healing are concerned, the main emphasis is put 
on the outcomes of experiments using a dietary FO/DHA/EPA administration, but the results of 
experiments with a parenteral application are also mentioned, together with selected relevant 
in vitro studies. An important conclusion from the above-mentioned studies is an inconsistency of 
FO/DHA/EPA effects on wound healing: decreased/increased collagen deposition; lower/higher 
counts of the inflammatory cells in the healing tissue; increased/decreased concentration of both 
pro- and anti-inflammatory cytokines; DHA accelerated/delayed wound healing process. Some 
experiments indicate superiority of DHA over EPA regarding wound healing.
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The present review deals with the effects of n-3 long-chain polyunsaturated fatty acids 
(LC-PUFA) in animal (especially rodent) models, the results of these experiments being 
also relevant to human health. Positive effects of n-3 LC-PUFA, especially eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA), on human health have been reported in 
cardiovascular diseases (Givens and Gibbs 2008), autoimmune diseases (Zárate et al. 
2017), foetal and neonatal brain development (Ruxton et al. 2005), dementia (Barberger-
Gateau et al. 2002), cognitive function (van Gelder et al. 2007) and wound healing 
(McDaniel et al. 2008). From these varied topics, the present review deals selectively 
with the potential of EPA and DHA (fish oil) to modulate particular phases of wound 
healing, especially (but not exclusively) cutaneous wound healing.
Long-chain polyunsaturated fatty acids n-3
Structure, metabolism, functions in an organism
In a mammalian organism, LC-PUFA n-3 (first double bond comes from the third carbon 
from the methyl end of the molecule), such as EPA (20:5 n-3), docosapentaenoic acid 
(DPA, 22:5 n-3) or DHA (22:6 n-3) can be synthetized from α-linolenic acid (ALA; 18:3 
n-3) by the action of desaturases and elongases (Das 2006; Jump 2008). The LC-PUFA 
n-3 are important components of the cell membranes (Das 2006), where they influence 
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membrane fluidity and behaviour of the integral membrane proteins and participate in 
regulation of many functions in the organism, including regulation of an inflammatory 
response (Schmitz and Ecker 2008), which is one of several overlapping phases of 
wound healing (Caetano et al. 2016).
Metabolism of n-3 PUFA in the mammalian organism should be considered together 
with metabolism of the n-6 group of PUFA originating in linoleic acid (LA; 18:2 n-6). 
Physiologically the most important metabolite of the n-6 group is arachidonic acid (AA; 
20:4 n-6; Zárate et al. 2017). The key metabolites of both EPA and AA (together called 
eicosanoids) are endoperoxides, such as thromboxanes and prostaglandins produced under 
catalysis of cyclooxygenase on the one hand, and leukotrienes produced by an action of 
5-lipoxygenase on the other hand (Nakamura et al. 2004; Das 2006; Jump 2008).
Eicosanoids produced from AA increase the tendency of thrombocytes to aggregate, act 
mostly as vasoconstrictors and have predominantly pro-inflammatory effects. EPA-derived 
eicosanoids have less pronounced and in many instances opposite effects in comparison 
with their AA-derived counterparts (Das 2006); inflammation modulating effect of 
EPA/DHA can make a difference especially in the initial phases of wound healing 
(McDaniel et al. 2008).
Functions of EPA/DHA on a molecular level are based (among others) on modulation 
of the signalling pathways mediated by transcription factors nuclear factor kappa B 
(NF-κB; Kostadinova et al. 2005), peroxisome proliferator-activated receptors (PPARs; 
Arai et al. 2009) and sterol response-element-binding protein (SREBP; Nakamura et al. 
2004; Jump 2008). Especially NF-κB and PPARγ are involved in signalling during the 
inflammation phase of wound healing. Inflammation is a relatively short part of the wound 
healing process, but its proper course is decisive from the viewpoint of a successful tissue 
remodelling and scar tissue formation (Otranto et al. 2010). Therefore the next part of the 
review is devoted to the evaluation of an EPA/DHA capability to modulate inflammation.
LC-PUFA n-3 as inflammation modulators 
Anti-inflammatory effects of EPA and DHA are based, among others, on the competition 
with AA in eicosanoid synthesis (Schmitz and Ecker 2008) and on modulation of 
signalling pathways mediated by transcription factors PPARα, PPARγ and NF-κB 
(Komprda 2012). 
EPA and DHA are endogenous ligands of PPARγ, whose activation increases the amount 
of the adipose tissue-derived anti-inflammatory hormone adiponectin (Siriwardhana 
et al. 2013). The EPA/DHA anti-inflammatory effect is further mediated by GPR120, 
a G-protein coupled receptor, whose activation leads to a repression of the macrophage-
induced inflammation (Flock et al. 2013). According to Oliver et al. (2010), EPA/DHA 
decreases plasma levels of pro-inflammatory markers interleukin 6 (IL-6), tumour necrosis 
factor alpha (TNF-α) or interferon γ (IFN-γ), and increases the concentration of anti-
inflammatory markers IL-10 and transforming growth factor beta (TGF-β).
During the acute inflammatory response, neutrophils are first to arrive at the site of 
inflammation and play an important protective role in innate immunity and host defence; 
however, excessive accumulation of neutrophils within the tissue can lead to tissue damage 
and amplification of the inflammatory response (Arita et al. 2005). Lipid mediators, such 
as prostaglandins and leukotrienes play pivotal roles in the initiation of acute inflammation, 
whereas resolvins and protectins, inflammation mediators derived from LC-PUFA 
n-3 (Serhan et al. 2015), promote and stimulate the active resolution of inflammation 
(Serhan and Savill 2005). The control of neutrophil infiltration is of wide interest in this 
situation, which underlines the importance of the above-mentioned resolvins and protectins 
(Dinarello 2010); resolution of acute inflammation is a central component of host defence 
and the return of tissue to homeostasis (Serhan et al. 2015). As an example, EPA-derived 
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resolvin E1 reduced leukocyte infiltration in a mouse peritonitis model and protected 
against the development of induced colitis, including decreased leukocyte infiltration and 
pro-inflammatory gene expression in a study by Arita et al. (2005).
As far as in vitro experiments are concerned, EPA and DHA decreased lipopolysaccharide 
(LPS)-induced pro-inflammatory IL-1β expression in 3T3-L1 adipocytes (Cranmer-Byng 
et al. 2015); Romacho et al. (2015) reported prevention of NF-κB activation (induced by 
TNF-α) in human primary adipocytes by EPA/DHA; DHA decreased degree of monocyte 
chemoattractant protein-1 and IL-6 secreted from murine adipocytes in an experiment of 
De Boer et al. (2014). 
Regarding in vivo experiments, fish oil (rich source of EPA) tended to reduce IL-1β and 
IL-12 production in LPS-challenged pigs (Liu et al. 2003), and n-3 PUFA intervention in 
LPS-challenged mice decreased levels of pro-inflammatory cytokines, including TNF-α 
(Liu et al. 2015). However, Hall et al. (2012) reported no substantial effect of fish oil (EPA 
and DHA) on pro-inflammatory cytokines in rodents. Similarly, Vigerust et al. (2013) 
found no significant differences between fish oil-fed and control animals in the hepatic 
concentrations of IFN-γ, IL-1β, IL-2 or IL-6; and the content of pro-inflammatory IL-17 
was even higher in the fish oil group.
An equivocal effect of fish oil on inflammatory markers was confirmed by Komprda 
et al. (2018) who reported a higher concentration of both anti-inflammatory IL-4 and 
pro-inflammatory TNF-α in plasma of fish oil-fed LPS-challenged pigs in comparison with 
the palm oil-fed controls. A diet rich in DHA did not affect the amount of the nuclear (i.e. 
active) fraction of NF-κB, but nevertheless increased the plasma level of anti-inflammatory 
TGF-β1 in rats with an induced state of a low-grade inflammation (Komprda et al. 2016). 
This part of the review can be concluded by stating that LC-PUFA n-3 have an equivocal 
effect on inflammation and thus on the subsequent stages of wound healing.
   
Wound healing
Definition and phases
Wound healing is generally defined as the process by which a body tissue (usually 
skin) repairs itself after trauma, a dynamic process aimed at restoring the structure of 
the injured tissue (Caetano et al. 2016). It is a sequential process that occurs in three 
overlapping stages: inflammation, cell proliferation and tissue remodelling (Gurtner et 
al. 2008), resulting in scar tissue formation (Otranto et al. 2010). Some authors divide 
wound healing into four phases: inflammation, coagulation, tissue formation and tissue 
remodelling (Caetano et al. 2016). This complex programmed sequence of cellular 
and molecular processes includes inflammation, cell migration, angiogenesis, synthesis 
of provisional matrix, collagen deposition and reepithelialisation (Gercek et al. 2007). 
From the viewpoint of regenerative veterinary/human medicine and a new field of tissue 
engineering, the process of wound healing can be divided into two major phases: the 
early phase and the cellular phase: the early phase leads to haemostasis and formation of 
a makeshift extracellular matrix, the cellular phase involves an inflammatory response, 
synthesis of the granulation tissue and restoration of the epithelial layer (Nguyen et al. 
2009).
Immediately after injury, platelets start to release cytokines and growth factors that recruit 
inflammatory cells and pro-inflammatory factors (serotonin, bradykinin, prostaglandins, 
thromboxanes, histamine) to stimulate local debridement, to degrade foreign particles and 
to provide provisional matrix for further proliferation of fibroblasts leading to formation of 
granulation tissue (Gurtner et al. 2008; Velnar et al. 2009).
The following phase is characterized by the formation of granulation tissue. Fibroblasts 
proliferate and migrate to the damaged tissue area in order to synthetize the new 
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extracellular matrix elements (Velnar et al. 2009; Guo and Dipietro 2010; Caetano 
et al. 2016), such as proteoglycans, glycosaminoglycans and collagen, which are deposited 
in the damaged area, where they replace the initial provisional matrix, comprised of fibrin 
(Campos et al. 2008; Velnar et al. 2009). The major structural component of granulation 
tissue, strengthening the extracellular matrix, is collagen, with an important constituent 
amino-acid proline, and hydroxyproline as a biochemical marker for collagen and an 
indicator of the progression of healing (Caetano et al. 2016).
When using animal (usually rodent) models for wound healing in humans, it is important 
to realize that while the closure of human wounds is primarily accomplished through 
proliferation and migration of cells at the wound edge, contraction is the driving force 
behind wound closure in rodents (Pensalfini et al. 2018). Nevertheless, the major cellular 
and molecular processes that occur during healing are conserved between both species and 
allow for rodent wounds to serve as a model for human wound repair (Galiano et al. 2004; 
Gurtner et al. 2008).
Markers for evaluation of the healing process
Planimetry (rate of healing)
To quantitate wound contraction and reepithelialization, a transparent plastic sheet is 
usually placed over the wound and its margins are traced (Nascimento and Costa 2006; 
Amadeu et al. 2007). After digitization, the wound area can be measured (Otranto et 
al. 2010). Nascimento and Costa (2006), and Otranto et al. (2010) estimated wound 
reepithelization in rats by the difference between the total lesion area and the wound area 
still uncovered with epidermis. Similarly, dos Santos Rosa et al. (2014) evaluated wound 
contraction and reepithelialization in mice by tracing the margins of the total wound area 
and nonreepithelialized wound area using a transparent plastic sheet.
Scardino et al. (1999) traced (on sterile transparent polyethylene sheets) the total wound 
area, the area of epithelium on the wound and the area of unepithelialized granulation tissue 
in the wound centre in Beagle dogs on the day of surgery and several postoperative days, 
aiming to calculate the percentage of wound contraction, the percentage of epithelialization 
and the percentage of total wound healing compared to the original wound. The percentage 
of wound contraction can be measured using the formula of Ramanathan et al. (2017): 
wound contraction (%) = [wound area (day 0) – wound area (day n)/ wound area (day 0)] 
× 100 – 3. McDaniel et al. (2008) defined wound healing as the advance of the wound 
margins toward the wound centre and measured a daily area yet to be healed by a noncontact 
method using an orientation card of known dimensions placed next to the wound sites, 
single digital camera photogrammetry (SCP), and a wound measurement software.
Amadeu et al. (2003) elaborated a stereological method of Baddeley et al. (1986) and 
Gundersen et al. (1988), which enables to obtain information about three-dimensional 
structures based on observations made in two dimensional structures. The authors 
(Amadeu et al. 2003) calibrated on the monitor the test system with cycloids, the minor 
axes of cycloids being arranged in parallel with the defined vertical axis. Skin fields were 
analysed in papillary and reticular dermis for surface density, length density and volume 
density for vessels and myofibroblasts using videomicroscopic system.
Tensile strength
For tensile strength measurements, not an excision, but an incision model of wound is 
usually used (Sathyanarayanan et al. 2017). The healed wound tissues are removed, 
harvested tissues are trimmed into strips of suitable length and width (with the original 
wound lying lengthwise in the centre of the sample), and apart from tensile strength (in 
MPa), a percentage of elongation at break (%) is usually measured (Ramanathan et al. 
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2017). Tensile strength increment indicates improved wound healing (Sathyanarayanan 
et al. 2017). 
Local strain analysis at a physiological level of tension using a multiscale mechanics 
approach to the characterization of murine excisional wounds subjected to uniaxial tensile 
loading showed the presence of two distinct regions within the wound in an experiment of 
Pensalfini et al. (2018): a very compliant peripheral cushion and a core area undergoing 
modest deformation. The authors reported negligible engagement of collagen located in the 
centre of a 7-day old wound with the compliant cushion at the wound periphery protecting 
the newly-formed tissue from excessive deformation at this phase; the early remodelling 
phase was characterized by a restored mechanical connection between the far field and the 
wound centre.
Assessment of collagen synthesis
The standard procedure for an estimation of the extent of collagenesis is based on the 
determination of hydroxyproline (Caetano et al. 2016). Hydroxyproline is produced 
post-translationally by hydroxylation of the amino acid proline and since this hydroxylation 
is almost entirely specific to the collagen protein, L-hydroxyproline (especially 
T4L- hydroxyproline) is an important marker for directly measuring the content of collagen 
in biological samples (Watanabe et al. 2015). Hydroxyproline comprises approximately 
13.5% of the mammalian collagen (Gorres and Raines 2010). 
Hydroxyproline is usually determined spectrophotometrically after the acid hydrolysis of 
the sample (Otranto et al. 2010; dos Santos Rosa et al. 2014). Morphometric analysis 
by Caetano et al. (2016) can also be used as a simple, rapid and low-cost technology 
for evaluating total collagen in cutaneous wound specimens. Nevertheless, a biochemical 
hydroxyproline assay is still frequently used (Gercek et al. 2007; Ramanathan et al. 
2017; Sathyanarayanan et al. 2017).
The method of Lin and Kuan (2010) includes chromophore formation without solvent 
transfers that allows the analysis of multiple specimens with excellent sensitivity, high 
specificity at low cost and shorter analysis time. The procedure of Colgrave et al. (2008) 
utilizes a highly selective and sensitive method of multiple reaction monitoring by mass 
spectrometry. Watanabe et al. (2015) developed a procedure using coupling systems with 
metabolic enzymes of the T4L- and T3L-hydroxyproline pathways from microorganisms 
and reported a successful hydroxyproline estimation within a broad range of wavelengths 
using a spectrophotometric assay, the results being consistent with those determined by 
high performance liquid chromatography.
It should be concluded however, that the hydroxyproline content reported in different 
experiments evaluating the effect of the same active substance (EPA, DHA) in a comparable 
phase of wound healing and applying various above-mentioned methods of hydroxyproline 
determination sometimes differs as much as by one order of magnitude and a comparison 
of the data obtained by different methods should therefore be taken with caution. 
Histopathology and immunohistochemistry (IHC) of cutaneous wound 
healing
Periodically collected samples of the granulation tissue from wound sites using 
predominantly a rodent model are usually evaluated (Nascimento and Costa 2006; 
Gercek et al. 2007; Otranto et al. 2010; dos Santos Rosa et al. 2014;  Ramanathan 
et al. 2017; Sathyanarayanan et al. 2017; Zhou et al. 2017). As far as histological 
preparations are concerned, samples of the healing tissue including ca 2 mm of skin 
surrounding the wound are usually taken, fixed in 10% buffered formalin, dehydrated by 
a gradual alcohol series, cleared in xylene, embedded in paraffin blocks, sectioned into 
a size of (usually) 5 µm thickness, stained with haematoxylin-eosin (H&E) and observed 
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under light microscopy. The evaluated markers are usually inflammatory cell infiltration, 
neovascularization (angiogenesis), fibroblast proliferation and epidermal remodelling 
(Gercek et al. 2007; Sathyanarayanan et al. 2017). Apart from H&E staining, Sirius red 
and toluidine blue can be used for evaluation of collagen fibres and mast cells, respectively 
(Nascimento and Costa 2006).
Regarding IHC assessment, paraffin embedded tissue sections, xylene-rehydrated and 
treated in a series of ethanol solutions are usually used (Ramanathan et al. 2017). If 
the detection of the searched-for protein is based on a reaction catalysed by a peroxidase 
(conjugated with a secondary antibody), endogenous peroxidases must be quenched 
beforehand by submersing the treated sections in a solution of H2O2 in methanol (Gercek 
et al. 2007). Rabbit polyclonal IgG (Ramanathan et al. 2017) or mouse monoclonal 
antibody (Otranto et al. 2010; dos Santos Rosa et al. 2014) are usually used as 
a primary antibody for immunostaining. Goat anti-rabbit antibody (Zhou et al. 2017) 
and biotinylated anti-rat antibody (dos Santos Rosa et al. 2014) are frequently applied 
secondary antibodies in this context. The last mentioned authors (dos Santos Rosa et al. 
2014) also used an anti-mouse secondary antibody conjugated with Alexa Fluor 647 for 
the detection of epithelial cadherin (E-cadherin) when evaluating cutaneous wound healing 
in mice. 
The following antigenic markers are most frequently detected by the semi-quantitative 
IHC procedures: alpha smooth muscle actin (α-SMA) (Zhou et al. 2017), e.g. in the blood 
vessel wall (Otranto et al. 2010) or in myofibroblasts (Nascimento and Costa 2006; 
dos Santos Rosa et al. 2014); myeloperoxidase-positive neutrophils, F4/80-positive 
macrophages, 4-hydroxynoneal-positive cells and E-cadherin (dos Santos Rosa et al. 
2014; see above). Other proteins, detected by IHC, with an important informative value 
regarding evaluation of cutaneous wound healing, include cyclooxygenase-2 (COX-2) and 
inducible NO synthase (iNOS; Ramanathan et al. 2017) or transforming growth factor 
beta (TGF-β) and platelet-derived growth factor (PDGF; Gercek et al. 2007). 
Genomic and proteomic markers of wound healing 
Expression of the genes that are active during the process of wound healing is usually 
evaluated by quantitative polymerase chain reaction (q-RT-PCR) after extraction of 
total RNA by (usually) guanidinium thiocyanate-phenol-chloroform extraction (TRIzol 
reagent; Figueroa et al. 2012) and a reverse transcription of messenger RNA (mRNA) to 
complementary DNA (cDNA; Turk et al. 2013; Ramanathan et al. 2017).
Expression of the following genes was mostly quantified in experiments evaluating 
the effect of EPA/DHA (fish oil) on wound healing: vascular endothelial growth factor 
(VEGF), epidermal growth factor (EGF) and transforming growth factor beta (TGFB; 
Ramanathan et al. 2017); TGFB1, cyclooxygenase 2 (COX2) and α-SMA (Zhou et al. 
2017); protein kinase B (Akt) and cyclic AMP responsive element binding protein (CREB; 
Figueroa et al. 2012); ACTA (coding for alpha skeletal muscle actin), COL1A1 (type 
I collagen), VIM (coding for vimentin, type III intermediate filament protein, marker of 
mesenchymal derived cells), CdH (coding for E-cadherin, cell adhesion molecule enabling 
formation of adherens junctions to bind cells with each other) and Snail (coding for zinc 
finger protein SNAI1, transcription factor promoting repression of E-cadherin to regulate 
epithelial-to-mesenchymal transition; Pastor-Clerigues et al. 2014); G-protein coupled 
receptor GPR120 (Arantes et al. 2016).
Due to the fact that inflammation is an important phase of wound healing, some authors 
quantified expression of the genes coding for pertinent cytokines/chemokines: interleukin 
(IL)-1β, IL-4, IL-6, IL-10, IL-13, IL-22, TGF-β, interferon gamma (IFNγ), tumour 
necrosis factor alpha (TNFα) and monocyte chemoattractant protein 1 (MCP1; Turk et 
al. 2013);  TNF-α, IL-1β and IL-6 (Weldon et al. 2007). Glyceraldehyde 3-phosphate 
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dehydrogenase (GAPDH) and β-actin are usually used as normalization (“housekeeping”) 
genes (Figueroa et al. 2012).
As far as expression on the protein level is concerned, Western blot procedure 
(including cell lysis by Triton X-100 and EDTA, inhibition of proteases, solubilisation 
with sodium dodecyl sulphate [SDS] and polyacrylamide gel electrophoresis [PAGE]; 
Turk et al. 2013) is usually applied (Chen et al. 2012; Chao et al. 2014; dos Santos 
Rosa et al. 2014).
Within experiments evaluating effect of PUFA n-3 on wound healing in general (not only 
skin lesions), following proteins were quantified using Western blot analysis: VEGF-A, 
VGEF receptor 2 (VEGFR2) and E-cadherin (dos Santos Rosa et al. 2014); COX-2, 
TGF-β1 and SMAD2/3 (mothers against decapentaplegic homolog 2/3, signal transducers 
for TGF-β1 receptors; Zhou et al. 2017); α-SMA, SMAD2/3, phospho-SMAD2/3, ERK 
(extracellular signal-related kinase), phospho-ERK and CD68 (Cluster of Differentiation 
68, protein strongly expressed  in monocytes and circulating macrophages, and also by 
tissue macrophages) and GGT (gamma-glutamyltransferase; Chen et al. 2012); EGFR 
(epidermal growth factor receptor), phospho-EGFR, PLC (phospholipase C) γ1 and 
phospho-PLCγ1 (Turk et al. 2013); ERK1/2, phospho-ERK1/2 and eNOS (endothelial 
NO synthase; Chao et al. 2014); phospho-SMAD3, phospho-ERK1/2, phospho-Akt and 
nuclear β-catenin (Pastor-Clerigues et al. 2014); cytoplasmic and nuclear p65 (nuclear 
factor NF-kappa B p65 subunit) and IκB-α (nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor-alpha, protein inhibiting the NF-κB transcription factor; 
Weldon et al. 2007).
Fish oil (eicosapentaenoic and docosahexaenoic acid) in wound healing
Dietary administration
As far as cutaneous wound healing is concerned, high fat diet, irrespective of the type 
of fat/oil, delays wound contraction and reepithelialization, increases the inflammatory 
infiltrate, delays myofibroblastic differentiation, collagen deposition, epithelial and 
connective tissue cell proliferation and angiogenesis (Nascimento and Costa 2006); 
the authors reported negative effects of a high-fat diet on rat cutaneous wound healing 
especially due to the prolongation of the inflammatory phase. 
Otranto et al. (2010) compared the effect of different edible oils (sunflower, linseed, 
fish) on cutaneous wound healing in rats and concluded that all edible oils delayed wound 
closure, and affected the inflammatory infiltrate and collagen deposition. However, in the 
fish oil group, more abundant inflammatory cells, high density of dilated blood vessels and 
high density of collagen fibres were found; the best results were achieved with sunflower 
oil. The authors (Otranto et al. 2010) are cautious regarding fish oil due to the increase in 
collagen synthesis possibly resulting in excessive scar tissue. Fish oil was also evaluated 
as a less suitable in comparison with olive oil in application to healing of excisional lesions 
in (rotationally) stressed mice in a study by dos Santos Rosa et al. (2014). Olive oil, but 
not fish oil, inhibited stress-induced reduction in wound contraction, reepithelialization, 
hydroxyproline levels and blood vessel density; fish oil (contrary to olive oil) was not able 
to reverse stress-induced increases in VEGF expression and number of macrophages and 
neutrophils.
On the other hand, Scardino et al. (1999), when comparing menhaden fish oil (with 
PUFA n-6/n-3 ratio of 0.3) and a control oil (PUFA n-6/n-3 ratio of 7.7) in wound healing 
in Beagle dogs, found in the fish oil group at five days post-surgery significantly less 
epithelialization of open wounds, less oedema in sutured wounds, and tendencies of less 
tissue perfusion, lower level of prostaglandin E2 and negative wound contraction in open 
wounds. Therefore, the authors concluded that PUFA n-3 does not appear to have an 
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outstanding long-term effect on wound healing due to (among other things) the lack of 
granulation tissue over which the epithelium would advance.
Several authors evaluated the efficiency of PUFA n-3 in healing of injuries different 
than cutaneous excisions/incisions. In cholestatic liver injury (induced by bile duct 
ligation, BLD) in rats, chronic DHA supplementation alleviated BLD-induced increase 
of TGF-β1, IL-1β, connective tissue growth factor and collagen expression (Chen et al. 
2012); DHA had an antifibrotic effect: decreased α-SMA-positive matrix producing cells 
and Smad 2/3 activity (i.e. fibrogenic potential of TGF-β1). DHA also decreased leukocyte 
accumulation and NF-κB activation. The authors concluded that DHA shows multifactorial 
hepatoprotective, anti-oxidative, anti-inflammatory and anti-fibrotic effect. 
According to Coelho de Castilho et al. (2015), preoperative supplementation with 
PUFA n-3 in rats was associated with increased collagen deposition of the type I fibres in 
colonic anastomoses on the 5th postoperative day; no differences in the tensile strength or 
collagen maturation index in comparison with control were found. Dietary supplementation 
with PUFA n-3 (in combination with ascorbic acid) improved (by additive action) the 
healing of ischemic colonic anastomoses in rats in a study by Ekçi et al. (2011). On the 
other hand, Drzymała-Czyż et al. (2012) reported higher intensity of inflammation 
and tissue expression of IL-1α and IL-10 in the DHA-fed group of rats that underwent 
restorative proctocolectomy (induced pouchitis) in comparison with control.
Based on the results of Figueroa et al. (2012), DHA protected and functionally improved 
the spinal cord injury in rats. A DHA pretreatment increased the percentage of white matter 
sparing (axonal preservation), and increased the survival of NG2+, APC+ and NeuN+ cells in 
the ventrolateral funiculus, dorsal corticospinal tract and ventral horns, despite the lack of 
inhibition of inflammatory markers for monocytes/macrophages and astrocytes. DHA also 
increased the levels of Akt and CREB mRNA and protein. Figueroa et al. (2012) therefore 
concluded that DHA-mediated activation of pro-survival/anti-apoptotic pathways may be 
independent of its anti-inflammatory effects. 
DHA decreased inflammation and joint destruction in mice with collagen-induced 
arthritis in an experiment of Olson et al. (2013); DHA, but not a mixture of DHA/EPA, 
decreased arthritis severity and joint damage, decreased level of the anti-collagen (CII) 
antibodies, downregulated IL-1β, IFN-γ and upregulated protective IL-10. According to 
the authors, the dietary administration of DHA is a useful intervention strategy against 
inflammatory arthritis.
Parenteral application
Arantes et al. (2016) applied a 30 µM DHA solution once a day as a topical treatment 
of a cutaneous excision in male Wistar rats. DHA significantly accelerated wound healing, 
promoted a reduction of IL-1β expression and increased expression of IL-6 and TGF-β; 
involved in this process was the molecular activation of GPR 120. However, in comparison 
with control, fish oil emulsion applied in rats on cutaneous wound healing showed a lower 
hydroxyproline level, shallower wounds, worse histologic score and lower expression score 
of TGF-β and PDGF-AA (Gercek et al. 2007); nevertheless, according to the authors, 
PUFA n-3 does not seem to have adverse effects on wound healing.
Hal l  et al. (2012) applied EPA or DHA intravenously in rats that underwent compression 
spinal cord injury (SCI). DHA, but not EPA, decreased neutrophil numbers in some areas 
of the injured epicentre and decreased plasma level of C-reactive protein. However, neither 
DHA nor EPA reversed the inflammatory response in the liver caused by the SCI, and 
neither was able to return to the control values the increased levels of IL-6, IL-1β and 
TNF-α in the SCI epicentre at 4 h after injury; therefore, the neuroprotective effects of LC 
PUFA n-3 in rat compression SCI can only partly be attributed to the reduction of early 
inflammatory events after injury.
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Comparative results of the in vitro  studies
DHA inhibited the development of non-small cell tumours (in the non-small cell lung 
cancer cell line A 459) through a ROS-mediated inactivation of the PI3K/Akt signalling 
pathway (Yin et al. 2017). When tested on the mouse immortalized colonocyte model, both 
EPA and DHA delayed (during the early response to intestinal wounding) the activation 
of key wound-healing processes in the colon (Turk et al. 2013) due to the reduced EGFR 
ligand-induced receptor activation, which was associated with a reduction in a downstream 
activation of cytoskeletal remodelling proteins. Chao et al. (2014) found that DHA 
inhibited VEGF-induced cell migration in a culture of umbilical vein endothelial cells, 
which implies that the effect of DHA on angiogenesis and wound repair is at least partly by 
virtue of its attenuation of cell migration. 
The effect of a fish oil commercial emulsion on inflammatory and pro-fibrotic liver 
markers was tested in culture supernatants of monocytes using a liver epithelial-to-
mesenchymal transition (EMT) induced by TGF-β1 (Pastor-Clerigues et al. 2014). 
Monocytes stimulated in vitro with LPS induced a strong inflammatory response that was 
suppressed by a commercial emulsion containing 100% of fish oil. This emulsion also 
suppressed the TGF-β1-induced EMT, contrary to the control soybean oil emulsion (which 
enhanced EMT).
Pretreatment with 100 µM EPA or DHA decreased the amount of TNF-α, IL-1β and IL-6 
proteins in the THP-1 monocyte-derived macrophages stimulated with LPS (Weldon et al. 
2007). Both EPA and DHA also decreased TNF-α, IL-1β and IL-6 mRNA expression, but 
DHA was more potent. Moreover, both EPA and DHA downregulated LPS-induced NF-
κB/DNA binding in the THP-1 macrophages, but only DHA decreased macrophage nuclear 
p65 expression and increased cytoplasmic IκB-α expression. The authors (Weldon et al. 
2007) concluded that DHA was more effective than EPA in alleviating LPS-induced, partly 
NF-κB-mediated, pro-inflammatory cytokine production in macrophages.
Summary
Based on the results of the pertinent experiments, effects of fish oil or its active constituents 
EPA/DHA on wound healing are very inconsistent. The amount of hydroxyproline and 
collagen deposition was increased in some experiments, but decreased in other ones. 
Regarding inflammatory cells, the numbers of macrophages and neutrophils were 
increased by fish oil, but the numbers of leukocytes were decreased by DHA. DHA either 
increased or decreased inflammation after injury; EPA/DHA were not able to reverse the 
inflammatory response and their protective effects seem to be only partly attributed to the 
reduction of the early inflammatory events after injury. As far as particular pro- and anti-
inflammatory markers are concerned, DHA both increased and decreased TGF-β; TGF-β 
was also decreased by fish oil. On the other hand, it seems that DHA consistently decreases 
IL-1β and TNF-α, and is able to increase IL-10. Therefore, it is not surprising that DHA 
likely mediates the activation of pro-survival/anti-apoptotic pathways independently of its 
anti-inflammatory effects.
Inconsistency also regards the wound healing rate: DHA both accelerated and delayed 
the wound healing processes in similar experiments. Finally, it follows from the results of 
some experiments that DHA is more effective in wound healing than EPA.
Conclusions of the above-mentioned literature data, including recommendations for future 
experiments can be formulated as follows: 1) The effects of long-chain polyunsaturated 
fatty acids (LC-PUFA) n-3 on wound healing tested on rodents are very inconsistent. 
2) Regarding mammalian skin morphology, an optimal model for wound healing in humans 
is a pig (Seaton et al. 2015); however, an application of LC-PUFA n-3 using a porcine 
model is not described in available literature. 3) Due to the unconvincing effects of dietary 
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LC-PUFA n-3 in physiological concentrations in in vivo experiments, it would be interesting 
to try to apply these fatty acids topically at higher concentrations in combination with 
nanoparticles; using nanoparticles in wound healing is extensive (Rajendran et al. 2018), 
but a description of their effects in combination with LC-PUFA n-3 is missing altogether in 
the given context. 4) A cutting-edge method of MALDI (matrix-assisted-laser-desorption-
ionization) with a detection of time-of-flight (TOF) can be used e.g. in a quantification of 
collagen in the tissues (Nimptsch et al. 2011), but again, its application in the evaluation 
of cutaneous wound healing in a porcine model using a combination of LC-PUFA n-3 and 
nanoparticles would be completely original. 
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